EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest
EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decrease of 23.9% from the November 30th total of 35,200 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 1.7 days.
Effector Therapeutics, Inc.（納斯達克股票代碼：EFTRW — 獲取評級）是12月空頭利率大幅減少的接受者。截至12月15日，空頭利息總額爲26,800股，較11月30日的35,200股減少了23.9％。根據16,000股的平均交易量，目前的交易天數比率爲1.7天。
eFFECTOR Therapeutics Price Performance
Effector 治療的價格表現
NASDAQ EFTRW remained flat at $0.16 on Friday. The company has a fifty day moving average of $0.13 and a 200-day moving average of $0.17. eFFECTOR Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.99.
週五，納斯達克EFTRW持平至0.16美元。該公司的五十天移動平均線爲0.13美元，200天移動平均線爲0.17美元。Effector Therapeutics的五十二週低點爲0.04美元，五十二週高點爲0.99美元。
Featured Stories
精選故事
- Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
- 免費獲取 StockNews.com 關於 Effector Therapeutics（EFTRW）的研究報告
- MarketBeat：本週回顧 12 月 26 日 — 12 月 30 日
- 科技之狗：是時候咬一口這些股票了
- 此次收購會使微軟成爲熊市買入嗎？
- 金塔拉療法是隱藏的寶石嗎？
- 你應該爲冬天的 Generac Stock 做熱身嗎？
Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 Effector Therapeutics 的新聞 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Effector Therapeutics及相關公司的最新新聞和分析師評級的簡明每日摘要。
